B Group, Inc.

Insider Reports History

Location
2900 Mckinnon Street, Suite 1101, Dallas, TX
Signature
/s/ Branden B. Muhl, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by B Group, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. 10%+ Owner Common Stock 3M $7.56M $2.52 Aug 18, 2025 Indirect

Insider Reports Filed by B Group, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRXP NRX Pharmaceuticals, Inc. Aug 18, 2025 0 $0 3 Aug 21, 2025 10%+ Owner